A new law in Virginia forbids pharmacists from dispensing a biosimilar substitution to a brand-name biologic drug if the prescribing physician specifies the prescription must be dispensed as written or if a patient wants the branded drug. Pharmacists must inform the patient before dispensing a biosimilar and must note the product name and manufacturer on the prescription label and dispensing record. Pharmacists also must give patients cost information on the branded and biosimilar products under the law, which would remain in effect until 2015.

Full Story:
Drug Store News

Related Summaries